-
1
-
2
-
3
-
4
-
5
-
6
Phase I dose-escalation pharmacokinetics of L-deoxythymidine (LDT) in patients with chronic hepatitis B virus (CHB) infection: Xiao-Jian Zhou, Novirio Pharmaceuticals, Cambridge, MA; Seng-Gee Lim, National Univ Hosp Singapore; Ching-Lung Lai, Univ of Hong Kong, Pok-Fu Lam Hong Kong; Robert L Murphy, Northwestern Univ, Chicago, IL; Deborah M Pow, Maureen W Myers, Novirio Pharmaceuticals, Cambridge, MA
Veröffentlicht in Hepatology (Baltimore, Md.)
VolltextArtikel -
7
Importance of second-phase HBV clearance and viral dynamic modeling for dose optimization of hepatitis B antiviral nucleosides: Xiao-Jian Zhou, Novirio Pharmaceuticals, Inc, Cambridge, MA; Seng Gee Lim, National Univ Hospital, Singapore Singapore; Nathaniel A Brown, Maureen W Myers, Deborah M Pow, Novirio Pharmaceuticals, Inc, Cambridge, MA; Ching-Lung Lai, Univ of Hong Kong, Pok Fu Lam Hong Kong
Veröffentlicht in Hepatology (Baltimore, Md.)
VolltextArtikel -
8
Safe and potent suppression of hepatitis B virus (HBV) with L-deoxythymidine (LDT): results of a dose-escalation trial: Ching-Lung Lai, Univ of Hong Kong, Pok Fu Lam Hong Kong; Maureen W Myers, Deborah M Pow, Nathaniel A Brown, Novirio Pharmaceuticals, Inc, Cambridge, MA; Yin-Mei Lee, National University Hospital, Singapore Singapore; Man-Fung Yuen, Univ of Hong Kong, Pok Fu Lam Hong Kong; Seng Gee Lim, National University Hospital, Singapore Singapore
Veröffentlicht in Hepatology (Baltimore, Md.)
VolltextArtikel -
9
New Antiretroviral Agents in the Clinic
Veröffentlicht in Reviews of infectious diseases
VolltextArtikel -
10
-
11
-
12
-
13
-
14
Current Status of HIV Therapy: I. Antiretroviral Agents
Veröffentlicht in Hospital practice (1995)
VolltextArtikel -
15
Defective-interfering particles of the human parvovirus adeno-associated virus
Veröffentlicht in Virology (New York, N.Y.)
VolltextArtikel -
16
Current Status of HIV Therapy: I. Antiretroviral Agents
Veröffentlicht in Hospital practice (1995)
VolltextArtikel -
17
-
18
-
19
-
20